Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
6.05
+0.05 (0.83%)
At close: Jul 8, 2026, 4:00 PM EDT
5.72
-0.33 (-5.45%)
After-hours: Jul 8, 2026, 7:54 PM EDT
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $362.26 million as of July 8, 2026. Its market cap has increased by 37.69% in one year.
Market Cap
362.26M
Enterprise Value
220.63M
1-Year Change
37.69%
Ranking
Category
Stock Price
$6.05
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $362.26M, a decrease of -35.93%. That is a compound annual growth rate of -7.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 352.28M | 15.36% |
| Dec 31, 2025 | 305.38M | 16.38% |
| Dec 31, 2024 | 262.40M | -3.64% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cybin | 373.76M |
| Abeona Therapeutics | 373.32M |
| Lyell Immunopharma | 371.25M |
| X4 Pharmaceuticals | 371.15M |
| Fennec Pharmaceuticals | 364.74M |
| Palisade Bio | 361.05M |
| Larimar Therapeutics | 355.95M |
| Fate Therapeutics | 352.01M |